Biotechnology Companies By Profit Margin
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Profit Margin
| Profit Margin | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | INBX | Inhibrx | 0.01 | 3.46 | 0.03 | ||
| 2 | NWBO | Northwest Biotherapeutics | (0.04) | 3.54 | (0.14) | ||
| 3 | AGIO | Agios Pharm | (0.03) | 2.54 | (0.07) | ||
| 4 | ADXN | Addex Therapeutics | 0.02 | 6.16 | 0.14 | ||
| 5 | PTGX | Protagonist Therapeutics | 0.10 | 6.50 | 0.65 | ||
| 6 | ADMA | ADMA Biologics | 0.08 | 3.36 | 0.27 | ||
| 7 | XOMAP | XOMA Corp | 0.04 | 0.54 | 0.02 | ||
| 8 | XOMAO | XOMA Corporation | 0.07 | 0.28 | 0.02 | ||
| 9 | HALO | Halozyme Therapeutics | 0.35 | 1.44 | 0.50 | ||
| 10 | UTHR | United Therapeutics | (0.08) | 2.33 | (0.19) | ||
| 11 | ARGX | argenx NV ADR | (0.03) | 1.68 | (0.05) | ||
| 12 | GMAB | Genmab AS | (0.02) | 2.81 | (0.07) | ||
| 13 | CPRX | Catalyst Pharmaceuticals | 0.10 | 3.35 | 0.33 | ||
| 14 | MAZE | Maze Therapeutics, Common | (0.13) | 5.23 | (0.67) | ||
| 15 | TRDA | Entrada Therapeutics | (0.24) | 3.30 | (0.78) | ||
| 16 | REGN | Regeneron Pharmaceuticals | (0.06) | 2.03 | (0.11) | ||
| 17 | KRYS | Krystal Biotech | 0.13 | 2.68 | 0.36 | ||
| 18 | GNFT | Genfit | (0.01) | 3.34 | (0.03) | ||
| 19 | GLPG | Galapagos NV ADR | (0.03) | 2.06 | (0.07) | ||
| 20 | EXEL | Exelixis | 0.08 | 2.44 | 0.20 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs. In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.